Literature DB >> 32424066

Correction: Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'.

.   

Abstract

Year:  2020        PMID： 32424066      PMCID： PMC7245411          DOI： 10.1136/esmoopen-2020-000675corr1

Source DB:  PubMed          Journal:  ESMO Open        ISSN： 2059-7029


× No keyword cloud information.
De Falco V, Poliero L, Vitiello PP, et al. Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania ‘Luigi Vanvitelli’. ESMO Open 2020;5:e000675. doi: 10.1136/esmoopen-2020-000675. Surname of the of the third author has been corrected from ‘Pietro Paolo Vitello’ to ‘Pietro Paolo Vitiello’.
  2 in total

1.  Implications of the germline variants of DNA damage response genes detected by cancer precision medicine for radiological risk communication and cancer therapy decisions.

Authors:  Noriko Hosoya; Kiyoshi Miyagawa
Journal:  J Radiat Res       Date:  2021-05-05       Impact factor: 2.724

2.  Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors.

Authors:  Masayuki Takeda; Takayuki Takahama; Kazuko Sakai; Shigeki Shimizu; Satomi Watanabe; Hisato Kawakami; Kaoru Tanaka; Chihiro Sato; Hidetoshi Hayashi; Yoshikane Nonagase; Kimio Yonesaka; Naoki Takegawa; Tatsuya Okuno; Takeshi Yoshida; Soichi Fumita; Shinichiro Suzuki; Koji Haratani; Kazumasa Saigoh; Akihiko Ito; Tetsuya Mitsudomi; Hisashi Handa; Kazuya Fukuoka; Kazuhiko Nakagawa; Kazuto Nishio
Journal:  Oncologist       Date:  2021-01-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.